Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.

Elevated growth hormone is a cardinal feature of acromegaly from the biological view point. Growth hormone stimulates IGF-I secretion and that of its major binding protein IGFBP-3. In these circumstances, where hyperinsulinaemia is present, IGFBP-1 levels, which are inversely related to insulin, are...

Mô tả đầy đủ

Chi tiết về thư mục
Tác giả chính: Wass, J
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 1997
_version_ 1826304392752529408
author Wass, J
author_facet Wass, J
author_sort Wass, J
collection OXFORD
description Elevated growth hormone is a cardinal feature of acromegaly from the biological view point. Growth hormone stimulates IGF-I secretion and that of its major binding protein IGFBP-3. In these circumstances, where hyperinsulinaemia is present, IGFBP-1 levels, which are inversely related to insulin, are suppressed. Failure of suppression of growth hormone after oral glucose (> 2 mU/l (1 microgram/l) is the cardinal biochemical feature of acromegaly. IGF-I values at diagnosis are almost invariably raised. There is some overlap in the value of basal IGFBP-3 between normal subjects and acromegalics. For monitoring purposes, growth hormone values, either basal or during the day are useful. There is overlap in the values of IGF-I and IGFBP-3 between normal subjects and patients on treatment. Prognosis in acromegaly is determined by persistent elevation of growth hormone levels above 5 mU/l (2.5 micrograms/ l). More data are required for the prognostic use of IGF-I.
first_indexed 2024-03-07T06:17:07Z
format Journal article
id oxford-uuid:f172cea7-062e-4e37-89d0-80dd8e03721a
institution University of Oxford
language English
last_indexed 2024-03-07T06:17:07Z
publishDate 1997
record_format dspace
spelling oxford-uuid:f172cea7-062e-4e37-89d0-80dd8e03721a2022-03-27T11:56:04ZGrowth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f172cea7-062e-4e37-89d0-80dd8e03721aEnglishSymplectic Elements at Oxford1997Wass, JElevated growth hormone is a cardinal feature of acromegaly from the biological view point. Growth hormone stimulates IGF-I secretion and that of its major binding protein IGFBP-3. In these circumstances, where hyperinsulinaemia is present, IGFBP-1 levels, which are inversely related to insulin, are suppressed. Failure of suppression of growth hormone after oral glucose (> 2 mU/l (1 microgram/l) is the cardinal biochemical feature of acromegaly. IGF-I values at diagnosis are almost invariably raised. There is some overlap in the value of basal IGFBP-3 between normal subjects and acromegalics. For monitoring purposes, growth hormone values, either basal or during the day are useful. There is overlap in the values of IGF-I and IGFBP-3 between normal subjects and patients on treatment. Prognosis in acromegaly is determined by persistent elevation of growth hormone levels above 5 mU/l (2.5 micrograms/ l). More data are required for the prognostic use of IGF-I.
spellingShingle Wass, J
Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title_full Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title_fullStr Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title_full_unstemmed Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title_short Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
title_sort growth hormone insulin like growth factor i and its binding proteins in the follow up of acromegaly
work_keys_str_mv AT wassj growthhormoneinsulinlikegrowthfactorianditsbindingproteinsinthefollowupofacromegaly